Actiq and Faslodex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Actiq (fentanyl citrate) and Faslodex (fulvestrant). Common drug interactions include neck pain among females and rash among males.

The phase IV clinical study analyzes what interactions people have when they take Actiq and Faslodex. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Actiq?

Actiq has active ingredients of fentanyl citrate. It is often used in pain. eHealthMe is studying from 27,583 Actiq users. Check the latest studies of Actiq.

What is Faslodex?

Faslodex has active ingredients of fulvestrant. It is often used in breast cancer metastatic. eHealthMe is studying from 19,255 Faslodex users. Check the latest studies of Faslodex.



On Jul, 08, 2026

29 people who take Actiq and Faslodex together, and have interactions are studied.

Actiq and Faslodex drug interactions.

What are the common drug interactions of Actiq and Faslodex, by gender? *:

female:

  1. Neck pain
  2. Pancoast's tumour (lungs tumour)
  3. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  4. Pericardial effusion (fluid around the heart)
  5. Sensitivity of teeth
  6. Spinal osteoarthritis (joint cartilage loss in spine)
  7. Tooth abscess (pus formation in tooth)
  8. Abdominal mass (localized enlargement or swelling in the human abdomen)
  9. Atelectasis (partial or complete collapse of the lung)
  10. Bone pain

male:

  1. Rash
  2. Abdominal pain
  3. Cardiac tamponade (fluid accumulates in heart covering)
  4. Cardiomegaly (increased size of heart than normal)
  5. Cardiopulmonary failure (cessation of normal circulation of the blood due to failure of the heart to contract)
  6. Cervicitis (inflammation of the uterine cervix)
  7. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  8. Colitis (inflammation of colon)
  9. Compression fracture (fracture due to pressure caused by injury)
  10. Constipation

What are the common drug interactions of Actiq and Faslodex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Abdominal distension
  2. Abdominal mass (localized enlargement or swelling in the human abdomen)
  3. Anaemia (lack of blood)
  4. Anxiety
  5. Aortic arteriosclerosis (hardening of the aortic arteries)
  6. Aortic calcification (aortic calcification sign of heart valve disease)
  7. Arthralgia (joint pain)
  8. Ascites (accumulation of fluid in the abdominal cavity)
  9. Atelectasis (partial or complete collapse of the lung)
  10. Back pain

20-29:

n/a

30-39:

n/a

40-49:

  1. Pain in jaw
  2. Pancoast's tumour (lungs tumour)
  3. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  4. Sensitivity of teeth
  5. Spinal osteoarthritis (joint cartilage loss in spine)
  6. Tooth abscess (pus formation in tooth)
  7. Vomiting
  8. Pericardial effusion (fluid around the heart)
  9. Abdominal mass (localized enlargement or swelling in the human abdomen)
  10. Atelectasis (partial or complete collapse of the lung)

50-59:

  1. Drug administration error
  2. Gait disturbance
  3. Hepatotoxicity (chemical-driven liver damage)
  4. Muscular weakness (muscle weakness)
  5. Nausea (feeling of having an urge to vomit)
  6. Vomiting

60+:

  1. Rash
  2. Abdominal pain
  3. Cardiac tamponade (fluid accumulates in heart covering)
  4. Cardiomegaly (increased size of heart than normal)
  5. Cardiopulmonary failure (cessation of normal circulation of the blood due to failure of the heart to contract)
  6. Cervicitis (inflammation of the uterine cervix)
  7. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  8. Colitis (inflammation of colon)
  9. Compression fracture (fracture due to pressure caused by injury)
  10. Constipation

What are the existing conditions these people have? *

  1. Metastases To Bone (cancer spreads to bone): 24 people, 82.76%
  2. Depression: 11 people, 37.93%
  3. Metastases To Bone Marrow (cancer spreads to bone marrow): 6 people, 20.69%
  4. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 3 people, 10.34%
  5. Breast Cancer: 3 people, 10.34%
  6. Aseptic Necrosis (the death of bone tissue due to a lack of blood supply): 3 people, 10.34%
  7. High Blood Pressure: 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Actiq and Faslodex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Actiq and Faslodex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Actiq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Faslodex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Actiq and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Faslodex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on fentanyl citrate and fulvestrant (the active ingredients of Actiq and Faslodex, respectively), and Actiq and Faslodex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: